PVWM
DGX icon

Point View Wealth Management’s Quest Diagnostics DGX Stock Holding History

Point View Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,831
Closed -$201K – 272
2018
Q2 		$201K Buy
+1,831
New +$191K 0.09% 234
2017
Q3 		– Sell
-1,831
Closed -$204K – 267
2017
Q2 		$204K Buy
+1,831
New +$194K 0.1% 225

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Point View Wealth Management's DGX Position: Q3 2018 in Review

Point View Wealth Management sold out of Quest Diagnostics (DGX) in Q3 2018, closing a stake of 1,831 shares — an estimated $201K sold.

Point View Wealth Management first reported a position in DGX in Q2 2017 and held it in 2 quarters. The position peaked at $204K in Q2 2017. 673 funds tracked by Wall St. Rank hold DGX as of Q3 2018.

  • Point View Wealth Management reported no remaining Quest Diagnostics position as of Q3 2018 after selling out during the quarter.
  • Point View Wealth Management sold 1,831 Quest Diagnostics shares in Q3 2018, an estimated $201K.
  • Point View Wealth Management first reported a position in Quest Diagnostics in Q2 2017 and held it in 2 quarters.
  • Point View Wealth Management's Quest Diagnostics position peaked at $204K in Q2 2017.
  • 673 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2018.

Based on Point View Wealth Management's 13F filing for Q3 2018, filed 8 Nov 2018.